CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab

Italian Melanoma Intergroup (IMI), Paola Queirolo, Beatrice Dozin, Anna Morabito, Barbara Banelli, Roberta Carosio, Vincenzo Fontana, Pier Francesco Ferrucci, Chiara Martinoli, Emilia Cocorocchio, Paolo A. Ascierto, Gabriele Madonna, Ester Simeone, Federica De Galitiis, Gian Carlo Antonini Cappellini, Paolo Marchetti, Michele Guida, Stefania Tommasi, Laura Ghilardi, Barbara MerelliPaolo Fava, Simona Osella-Abate, Massimo Guidoboni, Massimo Romani, Diego Ferone, Francesco Spagnolo, Maria Pia Pistillo

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)59-61
Number of pages3
JournalEuropean Journal of Cancer
Volume97
DOIs
Publication statusPublished - Jul 1 2018

Cite this